Microbiology Flashcards

1
Q

What are HAI?

A

Infections which occur within a certain period from contact with healthcare

~8% of patients in hospitals have an HAI in UK

Worldwide: 3.5-10.5% of hospitalised pts in industrialised countries; ~>25% in developing nations

We can categorise it based on organism:

  • –MRSA
  • –C. difficile
  • –E. coli
  • –MSSA
  • –R Gram negs
  • –Yeasts / Candida

Or by syndrome:

    • Catheter associated BSI
    • Urinary cath assocd UTI
    • Surgical site infection
    • Vent assocd pneumonia
    • Antibiotic assocd diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the impact of HAI?

A

Cost

  • Enormous – social / clinical / economic
  • UK: £1 Billion a year*
  • probable underestimate, very outdated, but often quoted
  • In 2004 DH estimate 300,000 HAI per year

Preventable?

  • Probably 15-30%
  • Financial incentives to prevent – non reimbursement
  • US leading the way
  • UK and others following
  • Unintended consequences

Perceptions of HAI

  • dirty hospitals
  • poor staff practise
  • affects pts who attended hospital for unrelated problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different types of HAI?

A

They come from the microbiome of patients and staff, as well as the environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the key strategies for infection control?

A

Reducing the number of bugs:

  • On equipment: sterilisation of equipment prior to operation
  • On environment: cleaning = dilution / reduction but not eradication
  • On patient: washing, skin preparation pre-op, prophylaxis for contaminated procedures
  • On staff hands: hand cleaning after contact any surface
  • On staff skin: ??

Reducing number of resistant bugs:

  • Screen patients – segregate those with organism detected from those in whom not detected
    • for certain organisms, evidence of organism burden reduction with topical suppression

Reduce transmission of bugs:

  • Staff - understand and use hand cleaning
  • Staff - cleaning environment and equipment
  • Staff - reduce use of broadest spectrum antibiotics and of unnecessary antibiotics
  • Systems - better design of surfaces with preventing adherence and transmission in mind
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are surgical site infections and what affects them?

A

3 things that affect SSI:

Host defence, wound environment and pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the challenges for outbreak control measures?

A
  • §Improved screening and isolation, impact of delays to typing results
  • §Laboratory and epidemiological investigations
  • §Internal and external communications. Coordinating briefing and discussions with external stakeholders.
  • §Input from other Trusts addressing CRE
  • §Hand hygiene and equipment focus, ward based adherence monitors
  • §Environmental cleaning and disinfection, attention to pillows and mattresses, HPV usage
  • §External reviews and visits of clinical areas
  • §Antimicrobial usage and stewardship
  • §Expediting discharges
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are HAIs changing over time?

A
  • •Invasive procedures
  • •Prosthetic and implantable devices
  • •Obesity
  • •Diabetes
  • •Extremes of age
  • •Immunosuppression
  • •Emerging organisms/ resistance

Hospital environment

  • •Environmental hygiene and cleaning
  • eg C. difficile, Norovirus, Acinetobacter outbreaks
    • chlorine agents; use of vapourised Hydrogen peroxide
  • •Control of environmental sources
  • Water: Legionella- cooling towers; Pseudomonas – all water; unusual Mycobacteria – all water
  • Building works – Aspergillus
  • •Negative pressure isolation – protection of others from an infectious patient with airborne infection
  • •Positive pressure isolation – protection of transplant patients from organisms from outside the room

Resistance:

  • •Widespread, prolonged use of antibiotics
  • •Broad spectrum antibiotics
  • •MRSA / VISA / VRE
  • •ESBL
  • •Multi-resistant / pan-resistant gram negatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is gastroenteritis and diarrhoea?

A
  • Gastroenteritis - A rapid onset diarrhoeal illness, lasting less than 2 weeks ¡with diarrhoea (loose and unformed stool) three or more times a day or at least 200 g of stool which is either viral or bacterial in aetiology
  • Diarrhoea – loose, or watery stool at least 3x in 24hrs: acute (less than 14d due to viral/bacterial), persistent (14-29d), chronic (>30d due to parasites and non-infectious aetiology should be excluded)

¡Small bowel diarrhea- often watery, associated with crampy abdominal pain and of large volume with bloating and gas. Accompanying fever and blood or inflammatory cells in the stool are rare.

¡Large bowel diarrhea –small volume painful stool which occur often with blood, mucus and inflammatory cells found in the stools and an accompanying fever.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the risk factors for gastroenteritis?

A
  • Food bourne
  • Exposure related – outbreak situation; travel hx (resource poor setting, cruise, recreational water facilities); occupational/healthcare exposure (c. diff); animal contacts (petting zoos/farms); reptiles (salmonella types with snakes and turtles) or other house pets with diarrhoea; institution/childcare facility
  • Host related – immunosuppressed, young children/elderly; men who have sex with men; haemochromatosis; ano-genital/oral-anal/digital anal contact; haemochromatosis or haemoglobinopathies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the epidemiology of gastroenteritis?

A
  • Underreporting of GI infections
  • Incidence of bacterial GE is less than viral GE and varies in countries and rural vs urban settings
  • Most are self limiting <24 hours, patients do not seek healthcare
  • Developing countries-outbreaks, cholera especially in war torn countries with no access to clean drinking water and sanitation
  • Most vulnerable groups: Infants, elderly, men who have sex with men, immunocompromised
  • Reportable: Campylobacter, Salmonella, Shigella, E.Coli 0157, Listeria, Norovirus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the mechanisms of disease in gastroenteritis?

A

3 types of disease:

Secretory diarrhoea - toxin production: cholera toxin, superantigens

Inflammatory diarrhoea

Enteric fever

inflammatory is exudative and enteric fever has interstitial inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the method of disease of cholera?

A

Cholera toxin -

cAMP: opens Cl channel at the apical membrane of enterocytes

>> efflux of Cl to lumen; loss of H2O and electrolytes

Efflux of water and ions which the body can’t keep up with replacing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are examples of superantigens?

A

In secretoy diarrhoea - toxin production: superantigens are produced

Superantigens bind directly to T-cell receptors and MHC molecules; outside the peptide binding site

>> massive cytokine production by CD4 cells ie systemic toxicity and suppression of adaptive response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference in mechanism of disease between inflammatory diarrhoea and enteric fever?

A

Host responses in bacteraemia:

Inflammatory (exudative ) diarrhoea Vs Enteric fever; interstitial inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can we diagnose gastroenteritis?

A
  • Stools taking shape of container tested with culture dependent or independent methods with PCR
  • Enteric fever – blood and stool tested with culture dependent and independent methods, bone marrow, duodenal fluid and urine also tested
  • Stools for microscopy and culture requested where enteric infection suspected
  • Stools for bac/viral/parasitic infection tested irrespective of blood in the stool, inflammatory markers or presence of fever or systemic syx if there is suspicion of an outbreak and if tested with molecular methodology, should be followed by culture for public
  • Can also tx based on the clinical feature -> each feature is specifically associated with a specific pathogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the extraintestinal manifestations of gastroenteritis and their causative organisms?

A

•Aortitis, osteomyelitis, deep tissue infections

–Salmonella, Yersinia

•Haemolytic anaemia

–Campylobacter Yersinia

•Glomerulonephritis

–Shigella, camp, Yersinia

•HUS

–STEC, shigella dysenteriae type 1

•Erythema nodosum

–Yersinia, camp salmonella shigella

•Reactive arthritis

–Salmonella, shigella, camp, Yersinia, giardia, cyclospora

•Meningitis

–Listeria, salmonella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Staph aureus?

A
  • •1/3 population chronic carriers, 1/3 transient
  • •Spread by skin lesions on food handlers
  • •Catalase, coagulase positive Gram positive coccus
  • •Appears in tetrads, clusters on Gram stain
  • •Yellow colonies on blood agar
  • Produces enterotoxin, an exotoxin that can act as a superantigen in the GI tract, releasing IL1 and IL2
  • Causing prominent vomiting and watery, non bloody diarrhoea
  • Don’t treat, self limited
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Bacillus cereus?

A

Gram positive rod - spore forming

Found commonly in reheated fried rice

  • •Heat stable emetic toxin -not destroyed by reheating
  • •Heat labile diarrhoeal toxin - food is not cooked to a high enough temperature

and

  • •watery non bloody diarrhoea; self limited
  • •Rare cause of bacteremia in vulnerable population
  • •Can cause cerebral abscesses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are clostridia?

A

Clostridium botulinum : botulism

  • •Source : canned or vacuum packed food (honey / infants)
  • •Ingestion of preformed toxin (inactivated by cooking)
  • •Blocks Ach release from peripheral nerve synapses
  • •Treatment with antitoxin

Clostridium pefringens : food poisoning

  • •Source : reheated food (meat) like Cosmos
  • •Normal flora of colon but not small bowel, where the enterotoxin acts (superantigen)
  • •Incubation 8-16hrs
  • •Watery diarrhoea, cramps,little vomiting lasting 24hrs

Clostridium difficile: pseudomembranous colitis

  • •3%, 30% of hospitalised patients
  • •It isn’t an invasive disease and non-toxin producing strains don’t cause disease but can colonise the gut and asyx shedders of spores can act as reservoir to infection
  • •2 toxins: A enterotoxin, B is cytotoxin
  • •A causes inflammation with intestinal fluid secretion and damage to mucosa
  • •B more potent than A and is a virulence factor
  • •Antibiotic related colitis (any but.. mainly cephalosporins, cipro and clindamycin)
  • •Infection control and preventions precautions required
  • Treatment : (PO) metronidazole, vancomycin, stop antibiotics where possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is listeria monocytogenes?

A
  • •Outbreaks of febrile gastroenteritis
  • •ß haemolytic, aesculin positive with tumbling motility
  • •Source : refrigerated food (“cold enhancement”),i.e. unpasteurised dairy, vegetables
  • •Grows at 4 ºC
  • •GI: watery diarrhoea, cramps, headache, fever, little vomiting
  • •Perinatal infection, immunocompromised patients
  • •Treatment : ampicillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are enterobacteriacae and give an example organism?

A

Facultative anaerobes, glucose/lactose fermenters (LF), oxidase negative

Escherichia coli :

  • •Traveller’s diarrhoea
  • •Source: food/water contaminated with human faeces
  • •Enterotoxins :
  • -Heat labile stimulates adenyl cyclase and cAMP
  • -Heat stable stimulates guanylate cyclase
  • -Act on the jejeunum, ileum not on colon

Types of e. coli

  • •Enterotoxigenic ETEC; toxigenic, main cause of traveller’s diarrhoea
  • •Enteropathogenic EPEC; pathogenic, infantile diarrhoea
  • •Enteroinvasive EIEC; invasive, dysentery
  • •Enterohaemorrhagic EHEC; haemorrhagic O157:H7 EHEC: shiga- like verocytotoxin causes HUS
  • •Avoid antibiotics – not beneficial for toxin process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are salmonellae bacteria?

A
  • Non lactose fermenters,
  • H2S producers,
  • TSI agar,
  • XLD agar,selenite F broth
  • Antigens:
  • -cell wall O (groups A-I)
  • -flagellar H
  • -capsular Vi (virulence, antiphagocytic)

•Three species :

  • -S. typhi (and paratyphi)
  • -S.enteritidis
  • -S.cholerasuis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are shigellae bacteria?

A
  • Non lactose fermenters, non H2S producers, non motile
  • Antigens:
  • -cell wall O antigens,
  • -polysaccharide (groups A-D) : S.sonnei, S.dysenteriae,

S.flexneri (MSM)

  • •The most effective enteric pathogen (low ID 10-100)
  • •No animal reservoir
  • •No carrier state

•Dysentery

  • invading cells of mucosa of distal ileum and colon
  • producing enterotoxin (Shiga toxin)
  • Abdo pain and watery diarrhoea

Avoid antibiotics (ciprofloxacin if required)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are vibrios?

A

•Curved, comma shaped, late lactose fermenters, oxidase positive.

Treat with doxycycline

Vibrio cholerae

  • •O1 group: epidemics, biotypes El Tor, Cholerae and serotypes Ogawa, Inaba, Hikojima
  • •Non O1 group: sporadic or non pathogens
  • •Transmitted by contamination of water and food from human faeces ( shellfish, oysters, shrimp)
  • •Colonisation of small bowel and secretion of enterotoxin with A and B subunit, causing persistent stimulation of adenylate cyclase
  • •Causes massive diarrhoea (rice water stool) without inflammatory cells
  • •Treat the losses

•Vibrio parahaemolyticus

  • -Ingestion of raw or undercooked seafood (ie oysters),
  • -major cause of diarrhoea in Japan..or when cruising in the Carribean.. ,
  • -self limited for 3 days
  • -cholerae : grows in salty 8.5% NaCl..

•Vibrio vulnificus

  • can cause diarrhea, but isolated from blood and tissues of septic patients
  • cellulitis in shellfish handlers
  • fatal septicaemia with D+V in HIV patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are campylobacter?

A
  • •Curved, comma or S shaped
  • •Microaerophilic
  • •C.jejuni at 42 ºC
  • •oxidase pos ,motile
  • •Self limiting but symptoms can last for weeks (20 days)
  • •Transmited via contaminated food and water with animal faeces
  • •Only treat if immunocompromised (macrolide)
  • •Transmitted via contaminated food and water with animal faeces ( poultry, meat,unpast. milk)
  • •Watery foul smelling diarrhoea, bloody stool, fever and severe abdo pain
  • •Loose stools occur >10x a day, bloody from 2/3rd day forwards
  • •? Enterotoxin (watery diarrhoea) ? Invasion (+/- blood)
  • •Treat with erythromycin or cipro if in the first 4-5days
  • •GBS syndrome, reactive arthritis, Reiter’s .. ​
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is Yersinia enterocolitica?

A

Non lactose fermenter, prefers 4ºC “cold enrichment”

Transmitted via food contaminated with domestic animals excretions

enterocolitis

mesenteric adenitis

associated with reactive arthritis , Reiter’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is entamoeba histolytica?

A
  • motile trophozoite in diarrhoea
  • non motile cyst in nondiarrhoeal illness
  • Killed by boiling, removed by water filters
  • 4 nuclei
  • No animal reservoir

Ingestion of cysts >> trophos in ileum >> colonize cecum, colon >> “flask shaped” ulcer

  • -dysentery, flatulence, tenesmus
  • -chronic : wt loss,+/- diarrhoea
  • -liver abscess

Diagnosis

  • -stool micro (wet mount, iodine and trichrome )
  • -serology in invasive disease

Treat : metronidazole + paromomycin in luminal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is Giardia lamblia?

A
  • trophozoite “pear shaped”
  • 2 nuclei
  • 4 flagellas and a suction disk
  • Ingestion of cyst from fecally contaminated water,food
  • •Excystation at duodenum
  • •tropho attaches
  • •no invasion
  • •malabsorption of protein and fat
  • At risk: Travellers, hikers, day care, mental hospitals, MSM
  • foul smelling non bloody diarrhoea, cramps, flatulence, no fever
  • Diagnosis : stool micro, ELISA, “string test”
  • Treatment :metronidazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is cryptosporidium parvum?

A

Parasite

  • Infects the jejunum
  • Severe diarrhoea in the immunocomromised
  • Oocysts seen in stool by modified Kinyoun acid fast stain

Treatment : reconstitution of immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is norovirus?

A
  • outbreaks
  • Low ID (18-1000 viral particles)
  • Environmental resilience (0-60 ºC)
  • No long term immunity
  • GII.4 currently predominant strain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is rotavirus?

A
  • dsRNA “wheel like”
  • Replicates in mucosa of small intestine

Mean duration 3-8d and occurs in children aged 6m-2yrs

Cause diarrhea in elderly

¡It can occasionally cause diarrhea in the elderly

¡Often year round in tropical climates and in the winter months in temperate areas

¡Vomiting is less of a prominent feature than in norovirus although it can be difficult to distinguish between them

Replicates in mucosa of small intestine

  • Secretory diarrhoea, no inflammation
  • Watery diarrhoea ? by stimulation of enteric nervous system
  • By age 6 most children worldwide have antibodies to at least one type
  • Exposure to natural infection twice confers lifelong immunity
  • Huge economic burden worldwide
32
Q

What is adenovirus?

A

Types 40, 41 cause non bloody diarrhoea <2yrs of age

•Any type in immunocompromised

Diagnosis : stool EM, antigen detection, PCR

transmitted via faecal-oral route but main presentations from other systems

33
Q

What are the vaccinations for GI infections?

A

•Cholera : serogroups O1(Inaba , Ogawa, biotypes El Tor and classical), O139

  • a.Inactivated, whole cell, contains all above + B subunit of toxin (PO)
  • b.Live attenuated (PO) not recommended
  • Campylobacter : military, infants,traveller, candidate vaccines exist..
  • ETEC : inactivated and live vaccines in trials
  • Salmonella typhi : Vi capsular PS (IM) and (PO)live

Rotavirus

  • • Rotarix : live attenuated human strain monovalent, 2(PO) doses
  • • Rotateq : pentavalent, 3 (PO) doses, one bovine and four human strains
  • •Rotashield and intussusception (8-20 weeks)
  • •Age of vaccine is 6-12 weeks
34
Q

What is the role of public health with GI infections?

A
  • Notifiable disease
  • Each trust to notify to local Health Protection Unit
  • Campylobacter, Clostridium sp, Listeria monocytogenes, Vibrio, Yersinia
  • Identify outbreaks in areas
  • Environmental Health Officers to inspect premises and take samples from environment and food
35
Q

What are the 3 targets for antibiotics?

A
  • Peptidoglycan layer of cell wall (1)
  • Inhibition of bacterial protein synthesis (2) (ribosome is different in prokaryotes)
  • DNA gyrase and other prokaryote-specific enzymes (3) (not present in eukaryotes)
36
Q

What are some inhibitors of cell wall synthesis?

A

(a) b-lactam antibiotics (penicillins, cephalosporins and carbapenems)
b) Glycopeptides (Vancomycin and Teicoplanin)

37
Q

What are the differences between GNB and GPB?

A
  • Gram positive cell wall (thick peptidoglycan layer) LEFT
  • Gram negative cell wall (has outer membrane, which is why they are more multidrug resistant) RIGHT
38
Q

What are b lactams?

A
  • Inactivate the enzymes that are involved in the terminal stages of cell wall synthesis (transpeptidases also known as penicillin binding proteins) – β-lactam is a structural analogue of the enzyme substrate
  • Bactericidal
  • Active against rapidly-dividing bacteria
  • Ineffective against bacteria that lack peptidoglycan cell walls (e.g. Mycoplasma or Chlamydia)
  • B-lactam only act on rapidly dividing bacteria, if it isn’t dividing, then it won’t work

Examples:

Penicillins, cefalosporins, carbapanems, monobactams

5% risk of allergy with the other classes if you have a penicillin allergy

KEY FACTS:

  • • Relatively non-toxic
  • • Renally excreted (so ↓dose if renal impairment)
  • • Short half life – have to be prescribed multiple times a day
  • • Will not cross intact blood-brain barrier, will cross inflamed meninges in meningitis
  • • Cross-allergenic (penicillins approx 10% cross-reactivity with cephalosporins or carbapenems)
39
Q

Examples of b-lactam antibiotics:

A

penicillin - Gram positive organisms, Streptococci, Clostridia; broken down by an enzyme (β-lactamase) produced by S. aureus (90% now resistant)

amoxicillin – Broad spectrum penicillin, extends coverage to Enterococci and Gram negative organisms ; broken down by β-lactamase produced by S. aureus and many Gram negative organisms

flucloxacillin- Similar to penicillin although less active. Stable to β-lactamase produced by S. aureus. – main treatment for S. aureus as not resistant to it

piperacillin – similar to amoxicillin, extends coverage to Pseudomonas and other non-enteric Gram negatives; broken down by β-lactamase produced by S. aureus and many Gram negative organisms

clavulanic acid and tazobactam – β-lactamase inhibitors. Protect penicillins from enzymatic breakdown and increase coverage to include S. aureus, Gram negatives and anaerobes; tazocin is the combination of piperacillin and tazobactam

40
Q

Give examples of cephalosporins

A
  • MRSA, C. diff -> problems with resistance
  • cefuroxime – Stable to many β-lactamases produced by Gram negatives. Similar cover to co-amoxiclav but less active against anaerobes
  • ceftriaxone – 3rd generation cephalosporin. Associated with C. difficile
  • ceftazidime – anti-Pseudomonas mostly
  • Extended Spectrum β-lactamase (ESBL) producing organisms are resistant to all cephalosporins regardless of in vitro results
41
Q

Examples of carbapenems:

A
  • Very broad, cover a huge spectrum of bacteria
  • Stable to Extended Spectrum β-lactamase (ESBL) enzymes
  • Meropenem, Imipenem, Ertapenem
  • Carbapenemase enzymes becoming more widespread. Multi drug resistant Acinetobacter and Klebsiella species.
42
Q

What are glyopeptides as antibiotics?

A
  • Large molecules, unable to penetrate Gram –ve outer cell wall
  • Active against Gram +ve organisms
  • Inhibit cell wall synthesis
  • Important for treating serious MRSA infections (iv only)
  • Oral vancomycin can be used to treat serious C. difficile infection
  • Vancomycin and Teicoplanin are examples of glycopeptides

MoA: Stop the transpeptidase from binding, no cross links forming, don’t let transglycosidase from binding – weakened cell wall causing the cells to die

  • Slowly bactericidal – not as active as b-lactams, which are usually first choice
  • Nephrotoxic – hence important to monitor drug levels to prevent accumulation
43
Q

What are the inhibitors of protein synthesis?

A

Aminoglycosides (e.g. gentamicin, amikacin, tobramycin)

Tetracyclines

Macrolides (e.g. erythromycin) / Lincosamides (clindamycin) (different class but linked with how they work)/ Streptogramins (Synercid) – The MSL group

Chloramphenicol (used more due to rise of resistance – used for CAP and meningitis for penicillin anaphylaxis pts)

Oxazolidinones (e.g. Linezolid)

44
Q

What are aminoglycosides?

A
  • Bind to amino-acyl site of the 30S ribosomal subunit
  • Rapid, concentration-dependent bactericidal action (need a high concentration for it to work properly)
  • Require specific transport mechanisms to enter cells (accounts for some intrinsic R)
  • Ototoxic & nephrotoxic, therefore must monitor levels – check levels in blood to check for accumulation, high trough levels which causes the toxicity
  • Gentamicin & tobramycin particularly active vs. Ps. aeruginosa
  • Synergistic combination with b-lactams (try to use b-lactams alone mainly)
  • No activity vs. anaerobes (useful with chloroforms)

MoA:

Bind to the 30S ribosome and prevent elongation of the peptide chain; but doesn’t show why they are bacteriacidal

45
Q

What are tetracyclines?

A
  • Broad-spectrum agents with activity against intracellular pathogens (e.g. chlamydiae, rickettsiae & mycoplasmas) as well as most conventional bacteria – don’t have a cell wall, most MRSA not resistant to it
  • Bacteriostatic
  • Widespread resistance limits usefulness to certain defined situations
  • Do not give to children or pregnant women
  • Light-sensitive rash – especially in the sun
46
Q

What are macrolides?

A
  • Bacteriostatic
  • Minimal activity against Gram –ve bacteria
  • Useful agent for treating mild Staphylococcal or Streptococcal infections in penicillin-allergic patients
  • Also active against Campylobacter sp and Legionella. Pneumophila – b-lactam with a macrolide for pneumonia tx to cover the atypicals
  • Newer agents include clarithromycin (long t ½) & azithromycin (good with gram negatives) with improved pharmacological properties

MOA: Can prevent toxins being produced, which is good for group A strep and nectrosing fasciitis, which would be added to a b-lactam, so you can add macrolides to prevent the toxins in severe skin infections

47
Q

What is chloramphenicol?

A
  • Bacteriostatic
  • Very broad antibacterial activity
  • Rarely used (apart from eye preparations and special indications) because risk of aplastic anaemia (1/25,000 – 1/45,000 patients) and grey baby syndrome in neonates because of an inability to metabolise the drug
  • Tx of choice for meningitis; not associated with c.diff diarrhoea

MOA:

•Chloramphenicol binds to the peptidyl transferase of the 50S ribosomal subunit and inhibits the formation of peptide bonds during translation

48
Q

What are oxazolidinones?

A

MOA: Binds to the 23S component of the 50S subunit to prevent the formation of a functional 70S initiation complex (required for the translation process to occur). Not derived from a natural source

Highly active against Gram positive organisms, including MRSA and VRE. Not active against most Gram negatives.

Is expensive, may cause thrombocytopoenia and should be used only with consultant Micro/ID approval; can get side effects with long term use; optic neuritis over 4wk use

49
Q

What are examples of abx which inhibit DNA synthesis?

A

Quinolones e.g. Ciprofloxacin, Levofloxacin, Moxifloxacin

Nitroimidazoles e.g. Metronidazole & Tinidazole

50
Q

What are fluoroquinolones?

A
  • Act on a-subunit of DNA gyrase predominantly, but, together with other antibacterial actions, are essentially bactericidal
  • Broad antibacterial activity, especially vs Gram –ve organisms, including Pseudomonas aeruginosa
  • Newer agents (e.g. levofloxacin, moxifloxacin) ­ activity vs G +ves and intracellular bacteria, e.g. Chlamydia spp; good for pneumonia typical and atypical; but worse for g -ve
  • Well absorbed following oral administration
  • Use for UTIs, pneumonia, atypical pneumonia & bacterial gastroenteritis
  • Decreased use due to resistance – e. coli and other gastroenteritis bugs (nearly all resistant)
  • Can cause tendonitis (stop taking if get tendon pain)
51
Q

What are nitroimidazoles?

A
  • Include the antimicrobial agents metronidazole & tinidazole
  • Under anaerobic conditions, an active intermediate is produced which causes DNA strand breakage
  • Rapidly bactericidal
  • Active against anaerobic bacteria and protozoa (e.g. Giardia)
  • Nitrofurans are related compounds: nitrofurantoin is useful for treating simple UTIs, not absorbed systemically, so useful with UTIs; less use of trimethoprim as resistance is high around 40%, but NFT still not resistant
52
Q

What are examples of abx which inhibit RNA synthesis?

A

Rifamycins, e.g. rifampicin & rifabutin

53
Q

What is rifampicin?

A
  • Inhibits protein synthesis by binding to DNA-dependent RNA polymerase thereby inhibiting initiation
  • Bactericidal
  • Active against certain bacteria, including Mycobacteria & Chlamydiae
  • Monitor LFTs
  • Beware of interactions with other drugs that are metabolised in the liver (e.g oral contraceptives) – NB with other Abx
  • May turn urine (& contact lenses) orange – all secretions, not harmful and then goes away

Altered target:

  • •Except for short-term prophylaxis (vs. meningococcol infection) you should NEVER use as single agent because resistance develops rapidly
  • •Resistance is due to chromosomal mutation – single point mutation
  • •This causes a single amino acid change in the ß subunit of RNA polymerase which then fails to bind Rifampicin.
  • •Should be used only in combination for TB and complex prosthetic infections – can destroy biofilm easily
54
Q

What are 2 antibiotics good against cell membrane toxins?

A

Daptomycin – a cyclic lipopeptide with activity limited to G+ve pathogens. It is a recently-licenced antibiotic likely to be used for treating MRSA and VRE infections as an alternative to linezolid and Synercid

Colistin – a polymyxin antibiotic that is active against Gram negative organisms, including Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. It is not absorbed by mouth.

  • It is nephrotoxic and should be reserved for use against multi-resistant organisms;
  • useful for MDR bacteria;
  • colistin attacks the outer membrane, so seen in combination with other antibiotics when we have no other options
55
Q

Which antibiotics are inhibitors of folate metabolisms?

A

Sulfonamides & Diaminopyrimidines (e.g. trimethoprim)

  • Act indirectly on DNA through interference with folic acid metabolism
  • Synergistic action between the two drug classes because they act on sequential stages in the same pathway
  • Sulphonamide resistance is common, but the combination of sulphamethoxazole+trimethoprim (Co-trimoxazole) is a valuable antimicrobial in certain situations (e.g. Treating Pneumocystis. jiroveci pneumonia)
  • Trimethoprim is used for Rx community-acquired UTIs
56
Q

What are bacterial mechanisms of resistance?

A
  • Chemical modification or inactivation of the antibiotic – b lactams
  • Modification or replacement of target
  • Reduced antibiotic accumulation

1) Impaired uptake
2) Enhanced efflux

•Bypass antibiotic sensitive step

57
Q

What are the examples of b-lactam inactivation mechanisms?

A
  • ß Lactamases are a major mechanism of resistance to ß Lactam antibiotics in Staphylococcus aureus and Gram Negative Bacilli (Coliforms).
  • NOT the mechanism of resistance in penicillin resistant Pneumococci and MRSA.
  • Penicillin resistance not reported in Group A (S. pyogenes), B, C, or G ß haemolytic Streptococci.
58
Q

What are examples of altered targets in beta lactams for abx resistance?

A

Methicillin Resistant Staphylococcus aureus (MRSA).

  • •mecA gene encodes a novel PBP (2a).
  • •Low affinity for binding ß Lactams.
  • •Substitutes for the essential functions of high affinity PBPs at otherwise lethal concentrations of antibiotic.

Streptococcus pneumoniae

  • •Penicillin resistance is the result of the acquisition of a series of stepwise mutations in PBP genes.
  • •Lower level resistance can be overcome by increasing the dose of penicillin used.
  • •Can be a problem in pneumococcal meningitis, which means you need to add vancomycin to overcome the resistance
59
Q

What are Extended spectrum b lactamases?

A
  • Able to break down cephalosporins (cefotaxime, ceftazidime, cefuroxime)
  • Becoming more common in E. coli and Klebsiella species.
  • Treatment failures reported with ß Lactam/ ß Lactamase inhibitor combinations (eg. Augmentin/Tazocin).

Scary how much ESBLs spread and multiplied

Spread lots of different resistance genes when giving the ESBL gene; including disinfectants and other drugs

60
Q

What are examples of altered targets with macrolides?

A
  • Adenine-N6 methyltransferase modifies 23S rRNA
  • Modification reduces the binding of MLS antibiotics and results in resistance
  • Encoded by erm (erythromycin ribosome methylation) genes

Affects glucosamides too; causes methylation and alteration of the ribosomal proteins.

61
Q

What are the natural hosts for influenza?

A

Type A Viruses have a reservoir in the ducks; no pandemic from type B and type C; 16 different H subtypes of influenza A in wild birds and 2 in bats; which then goes to chickens and spreads through those animals

Doesn’t cause any problems to these birds – adapted to coexist with these species

Zoonosis – dead end virus; but if it undergoes many transmutations, then turns from animal virus to a human virus, which can then transform into seasonal influenze undergoing antigenic drift; all influenza in humans today was originally a pandemic flu which was from an avian flu.

62
Q

How does the influenza virus adapt from a bird flu to become pathogenic to humans?

A

Fristly: needs activation by host cell proteases only expressed in respiratory tract -> hence why causes respiratory disease

Influenza generates haemagluttinin which needs to be cut into 2 pieces is found in respiratory section of lung – human airway tryptase -> then can cause this multiplication, propagation and spread

These viruses are very pathogenic in chickens which then replicate very rapidly, leading to v severe disease and can detect the virus outside the lungs, in the blood -> due to cleavage of haemagglutinin

H7N9 avian influenza in China: Not highly pathogenic at the beginning – just restricted at first to a specific part of the body; series of waves of pandemic – emergence of highly pathogenic multibasic cleavage protein had appeared -> due to a massive poultry vaccination project the number of infected have decreased completely

Infection of humans with unadapted avian influenza virus can lead to hypercytokinaemia

63
Q

What are the 3 factors needed for influenza to become a pandemic?

A

•A pandemic virus will have novel antigenicity.

•A pandemic virus will replicate efficiently in human airway.

•A pandemic virus will transmit efficiently between people.

1918 influenza virus and all subsequent human viruses of 20th century have PB2 627K . Replication can be achieved by a single amino acid change in polymerase PB2 E627K; human infections with avian flu associated with severe disease carry pb2 e627k mutation -> a few days after infection the flu will switch to this mutation as it is essential to replicate and adapt to grow in human airway; severe ones such as H5N1 and H7N9 infections

H5N1 and H7N9 and influenza viruses still don’t infect humans properly; but the mutation can occur in 1 of 2 ways -> acquire as it replicates in the airway OR in influenza is segmented, meaning the genome of the virus, which means that if 2 different viruses nter the same cell, the virus leaving can contain genetic material from both called REASSORTMENT!

This is what led to the swine flu -> H3N2; these viruses still need further reassortment and adaptations of their haemagglutinins

Transmission:

  • Via droplet - aerosol or fomite (drop on object)
  • Features which affect transmission: Receptor binding, virion stability and NA stalk length
  • Avian influenza bind to syalic acids which are bound to the alpha 2 linkage;
  • in resp tract we have more alpha 6 linkage, so won’t bind and enter that cell very efficiently;
  • unless it mutates and changes the haemagglutinin which changes preference to alpha 2,6 receptor;
  • also needs to be stable to be able to survive in water droplets, as they get more and more concentrated - mutations of haemagg which can stabilise the whole haem which canmaintain air borne transmission
  • Neuraminidase tends to be short in length in chicken adapted viruses, very long in human mucous barriers, to reach the human airway cells -> if all 3 happen then we can have the next pandemic -> in h5/h7/h10-13 who knows?
64
Q

What happened with Swine flu pandemic in 2009?

A
  • Nearly 9000 hospitalizations in the UK, more than 800 deaths
  • Globally 200,000 deaths
  • Seropositivity in London and Birmingham >40% in children by September 2009 (Miller et al. 2010)
  • Case fatality ~ 0.02%
  • Mild disease in majority of cases.
  • 50% of those hospitalized were previously healthy (FLUCIN Thorax 2010).

Elderly were relatively spared -> most of those affected were between 0-5 and 15-44

Inherited the gene from the 1918 Spanish flu, which infected some pigs and stayed within pigs for decades -> pigs don’t live for very long, so not much selective pressure so the virus remained evolutionary static; hence why the elderly popn had immunity to this flu

Reasons why there were severe outcomes from swine flu H1N1 ->

  • •High dose, route of exposure
  • •Mutant virus (D225G mutation in HA associated with 25% fatal cases in Norway)
  • •Bacterial superinfection (Odds ratio of 125 after other factors accounted for in Argentinian study)
  • •Co morbidity: Asthma, pregnancy, obesity, diabetes
  • •Genetic predisposition: IFITM3 mutation - loss of gene linked with severe influenzza, the CC variant of it; ethnic bias

Quite often the 3rd wave is even more severe – maybe due to the virus mutating and then by the 3rd wave it has improved so much that it can now spread much faster; OR could be in 2011 the winter was much colder

65
Q

How can we control an influenza outbreak?

A

Can’t detect whether people are incubating flu ro contagious. With flu they are waking around for a day before they get sick

Public health measures are difficult -> economic impact and length of time for isolation to prevent this is too high for gov to do this

Antivirals:

  • Amantadine
    • •Targets M2 ion channel
    • •Single amino acid mutation in M2 (S31N) renders virus resistant
    • •Does not work against influenza B or pH1N1 or seasonal H3N2
    • •Used them too much when discovered as nearly every virus now has resistance to these drugs
  • Neuraminidase inhibitors and mode of administration: most common ones used
    • Tamiflu (oseltamivir) oral - halves the chance of dying from flu if drug given within 48hrs
    • Relenza (zanamivir) inhaled or iv formulation
    • Peramivir iv
    • Inhibits neuraminidase protein
  • Polymerase inhibitors:
    • Favipiravir (licensed in Japan excluding pregnant women)
    • Baloxavir (licensed in Japan and USA) – inhibits the PA endonuclease when compared with placebo it improves symptoms; attack replication capacity of the virus which could decrease the amount of transmission -> comparing it to oseltamivir, decreases the amount of virus shed from the infected person

BUT emergence of drug resistant variants have occurred - in prophylaxis only give half doses and we don’t combine 2 drugs like in HIV

  • Influenza is best controlled using vaccines but
  • There will be no specific matched vaccine for a novel pandemic virus in the short term
  • Takes around 6m from getting virus, sequencing, vaccine manufacture, getting enough doses and the first wave of pandemic will be over and many will die
  • But will be 2nd and 3rd waves of pandemic so will be useful
66
Q

Which influenza vaccine do we use in the UK?

A

Children in uk played a huge role in spreading the pandemic of H1N1 1st wave – so might be able to benefit from just vaccinating children – as they would benefit and not get ill and not spread it far

Vaccine given to those at greater risk of complications from flu:

  • A purified fraction containing HA and NA of an inactivated virus
  • •Trivalent or quadrivalent inactivated vaccine
  • •Split or subunit- HA rich
  • •Given to those at risk
  • •Short term strain specific immunity mediated by antibody to HA head
  • •Adjuvants introduced to boost response in elderly

In children:

  • •Live attenuated vaccine, also tri or quadrivalent
  • •Cold adapted virus limited to urt
  • •Given to children – all school age children
  • •Broader more cross reactive immunity including cellular response

For HCW:

  • •More than 1 million HCWs have direct patient care and all are offered influenza vaccines.
  • •2012/13 year the uptake rate for seasonal vaccine was 44.5%, for 2017/18 it was 68.7%.
  • •Flu vaccine (for adults) does not give you flu.
  • • A person infected with influenza virus is contagious before they know they are infected.
  • •By not getting flu vaccine you put your vulnerable patients at risk.

Pandemic vaccines:

  • •Inactivated vaccines to novel HA proteins require adjuvant to generate a robust immune response
  • •Novel oil-in-water adjuvants used in monovalent vaccines AS03 Pandemrix: Narcolepsy side effect! - Think there was an autoimmune reaction to the virus which induced a cross reaction to hypocretin receptor which meant it caused narcolepsy

Can we make a universal vaccine:

Most vaccines affect the head region of the virus, which mask/interfere with the reaction of the receptor -> but in the stem are a set of amino acids which are highly preserved between all the different strains of influenza which means we could protect against all flu viruses

  • •Whole virus vaccines produced in Vero cells immunogenic without adjuvant Celvapan
  • •ALWAYS take it!
67
Q

What are the different pathologies of diarrhoeas according to incubation period?

A

longer than a day then think about enteric bacteria; stool bloody and secretory; more chronic = parasites and c.diff

68
Q

What is the difference between S enteritidis and S typhi?

A

Enterocolitis - S enteritidis

  • •Transmitted from poultry, eggs, meat
  • •Invasion of epi- and sub-epithelial, tissue of small and large bowel
  • •Bacteraemia infrequent <5%
  • ¡Diarrhea resolves in 4-7 days with abdominal pain
  • ¡Nausea, vomiting and fever usually resolves in 48 to 72 hours
  • ¡Salmonella gastroenteritis is usually self limiting and does not require treatment for immune-competent patients aged between 12-50 years of age where the risks of antibiotic therapy and potentially prolonging carriage outweigh the benefit
  • •Stool positivity

S. typhi:

  • Typhoid (enteric) fever
  • ¡transmitted only by humans
  • ¡multiplies in Payer’s patches, spreads ERS
  • ¡bacteraemia, 3% carriers
  • ¡Slow onset, fever and constipation,
  • ¡splenomegaly,rose spots, anaemia, leucopaenia,
  • ¡bradycardia, haemorrhage and perforation
  • ¡Blood culture positive 40-80%
  • ¡Stool culture positivity is 30-40%
  • ¡Bone marrow may have additional yield >90% in more complicated cases or if unresponsive to treatment and can remain positive for >5 days after antibiotic initiation
  • ¡Treatment : ceftriaxone
69
Q

What are opportunistic infections?

A

Occur more frequently in immunocompromised - Impaired ability to respond normally to an infection

◦CMV, EBV, HSV

More severe presentation

◦VZV, Measles.

Absence or diminution in signs of infection

Fever could be due to non-infectious causes

Relative risk of opportunistic viral infections:

Highest risk

  • Allogeneic stem cell transplant (most immunosuppressed)
  • Advanced HIV infection (CD4 dep)
  • Solid organ transplant
  • Various monoclonal antibody therapies
  • Cytotoxic chemotherapy
  • DMARDs and steroids
70
Q

How do transplants cause immunosuppression?

A

Both have a period of time where the IS is turned off -> level of immunosuppression required -> solid organ patietns need continued immunosuppression, but stem cell can eventually reduce their levels and have a normal life

Epidemiological exposure in transplant recipients:

  • Virus acquired from graft like HBV- serostatus and risk assessment; usually occurs within 4 weeks from transplant
  • Virus reactivation from host like HSV - serostatus, monitoring, prophylaxis, pre-emptive therapy; usually occurs between 1-12m from transplant. Examples:
    • adenovirus, EBV, hepB/C, HSV, HHV6/7, VZV kind of
  • Novel infection from infected individual like VZV - isolation barrier nursing, advice for family/contacts, post-exposure prophylaxis, vaccinating contacts, control of diet; occurs 12m after transplant
    • respiratory viruses CMV, HPV, JC virus, PML, PTLD, VZV

The development of infections in solid organ transplantation vs bone marrow transplants are different, with solid organ transplants having a longer timescale for infection 1-6m and encompasing bacteria from wound/UTI; opportunistic infections such as CMV, MTb, listeria, candida.

Bone marrow transplants have a much shorter timescale over 1-4m, with most infection occurring in the first few months: GNR bactaraemia, HSV, CMV, oral candidia, deep candidiasis, aspergillosis; parasites: pneumocystis, toxoplasma, VZV

List of serology done before transplantation – need to monitor the infections which occur later on – know that they are going to get adeno more common, that’s why need to check for this one

CMV monitoring or prophylaxis; EBV monitoring; Adeno monitoring (paeds BMT); HSV prophylaxis if indicated

  • •HIV Ag/Ab
  • •HBV sAg
  • •HBV cTAb
  • •HBV sAb
  • •HCV Ab
  • •EBV IgG
  • •CMV IgG
  • •HSV IgG
  • •VZV IgG
  • •HTLV Ab
71
Q

How do we treat opportunistic viral infections?

A
  • Opportunistic viral infections are often more difficult to treat
  • Often requires
  • –Early treatment
  • –higher dose
  • –longer course
  • –sometimes drug combinations

•Increased risk of antiviral drug resistance

72
Q

What are the human herpes viruses?

A

•Human herpes viruses

  • –Herpes simplex virus (HSV) 1 & 2
  • –Varicella zoster virus (VZV)
  • –Cytomegalovirus (CMV)
  • –HHV6 : Human herpes virus 6
  • –Epstein Barr Virus (EBV)
  • –HHV-8
  • DNA viruses
  • Latent infection
  • –Only a small subset of genes are expressed
  • –Reactivation can occur leading to the expression of viral genes and production of progeny virus

•Leads to destruction of the host cells

Herpes simplex virus

Most commonly

  • Cold sores, stomatitis, mouth ulcers
  • Recurrent genital disease (HIV and adult transplant

Serious complications – mainly immunocompromised patients

  • Cutaneous dissemination
  • Oesophagitis
  • Hepatitis
  • Viraemia

Treatment

  • Aciclovir or valaciclovir
  • Foscarnet more commonly used
  • (Ganciclovir sensitive also)

Varicella Zoster

•Varicella (primary infection)

Carries an Increased risk of complications in immunocompromised:

  • –Pneumonitis
  • –Encephalitis
  • –Hepatitis
  • –Purpura fulminans in neonate
  • •Shingles -often late complication post-transplant
    • •Shingles can be early sign of HIV infection-indication for HIV testing particularly in young person
    • •Immunocompromised it appears as Multidermatomal or disseminated zoster is associated with high mortality
  • Acute retinal necrosis
  • Progressive outer retinal necrosis
  • VZV associated vasculopathy

Prevention:

  • Acyclovir prophylaxis offers some protection
  • Post exposure porphylaxis - VZIg (now not commonly used) or acyclovir

Cytomagalovirus

Symptoms: encephalitis, retinitis (HIV mainly), pneumonia, gastroenteritis/colitis (transplant)

In transplant the risk of CMV disease relates to pre-tx serostatus

  • solid organ transplant
    • D+/R- : carries the greatest risk of reactivation
    • tx: valganciclovir prophylaxis for 100d
  • bone marrow transplant: adoptive immunity
    • D-/R+ : carries the greatest risk of reactivation, as patient has CMV in body, but the new bone marrow won’t be able to cope with it
    • tx: CMV viral load twice weekly, treat if reactivation until suppression - pre-emptive therapy
  • D = donor, R = recipient

Treatment:

  • •Ganciclovir (IV): bone marrow suppression
  • •Valganciclovir: oral
  • •Foscarnet (IV) (nephrotoxicity)
  • •Cidofovir (nephrotoxicity)
  • •IVIg (with another drug for pneumonitis)

Epstein-Barr Virus

Post-transplant lymphoproliferative disease (PTLD)

  • ◦Latently infected B cells – polyclonal activation
  • ◦Predisposes to lymphoma
  • ◦suspicion on rising EBV viral load (> 105 c/ml) and CT scan
  • ◦Confirmation with biopsy of lymph nodes

Kaposi’s sarcoma - HHV8

  • Pre-HIV epidemic indolent tumour of elderly men in Mediterranean
    • -Presents as a brownish/purplish vascular lesion, can be cutaneous or visceral
    • -Diagnosis made by biopsy
    • -Treated by chemotherapy and the initiation of antiretroviral therapy
  • More rare as now have retrovirals; can be on any solid organ/skin so can be seen in eyes
  • generally not considered a true sarcoma, which is a tumor arising from mesenchymal tissue
  • Trtt: Radiotherapy, surgical, INF alpha, chemo
73
Q

What are examples of polyomavirus?

A

JC virus:

  • JC virus is a polyomavirus
  • Effective antiretroviral therapy has drastically reduced PML incidence in HIV+ve patient (PML = progressive multifocal leukoencephalopathy)
  • PML can be seen in other types of immunosupressed hosts:
  • i.e patients on humanised monoclonal antibodies such as Natalizumab (for treatment of multiple sclerosis)
  • Seen in MS too ^
  • PML:
    • •Cognitive disturbance, personality change, motor deficits other focal neurological signs
    • •The main pathological feature of PML is a demyelination of white matter with neurological deficits corresponding to the area(s) of the brain affected
    • Tx: with antiretrovirals
    • •Diagnosis: MRI and PCR on CSF ​

BK virus -> BK cystitis:

  • •Polyomavirus
  • •Double stranded DNA
  • •BK cystitis post SCT
  • •BK nephropathy post Renal Tx
  • •Cause of haemorrhagic cystitis after transpolant SCT
74
Q

What is adenovirus?

A
  • Particular problem post-BMT
  • Exogenous infection or reactivation of persistent endogenous infection.
  • Fever
  • Encephalitis/Pneumonitis/Colitis
  • High mortality with disseminated infection.
75
Q

What are the different respiratory viruses in the immunocompromised and their treatments?

A

•Increased risk of complications (pneumonitis) and high mortality associated particularly with:

  • –Influenza A and B
  • –Parainfluenza 1, 2, 3 and 4
  • –Respiratory Syncitial Virus (RSV) infection
  • –Adenovirus
  • –Novel coronavirus: MERS coronavirus

Tx:

  • •Influenza A and B
    • –Oseltamivir (oral drug) for 5 days
    • –If severely immunosupressed:
      • •risk of oseltamivir resistance in influenza A
      • •zanamivir (inhalation or IV) is an alternative
  • •Other respiratory viruses do not have a standard treatment protocol
  • •Not much you can do but supportive management
76
Q

What is hepatitis B?

A

The virus is one of the smallest enveloped animal viruses, but pleomorphic forms exist, including filamentous and spherical bodies lacking a core. These particles are not infectious and are composed of the lipid and protein that forms part of the surface of the virion, which is called the surface antigen and is produced in excess during the life cycle of the virus.

The core protein is the major component of the nucleocapsid. HBeAg may be generated from the core protein by proteolytic cleavage.

HBsAg will increase, but as resistance increases, the virus is cleared so the Ag decreases

•Two things can happen:

  • –Carriers may have flare of disease.
  • –Those who have had past infection can reactivate
  • •The risk of reactivation is particularly important with patients on B-cell depleting therapies (i.e Rituximab)
    • –Might not have cleared it in the first place, depleted their cells

•Prevention:

  • –Nucleoside/nucleotide analogues (eg lamivudine, tenofovir, entecavir) prophylaxis -> viricidal drugs to kill hepB
77
Q

What is hepatits E?

A
  • •HEV is endemic in the UK (and in much of Europe)
  • •has now become the major cause of enterically transmitted viral hepatitis
  • •Predominantly from eating contaminated food, like pork
  • •Get a diarrhoeal illness like hepA in normal; immunocompromised get a viraemia
  • •In developed countries:
    • –HEV infection is a zoonosis caused by genotype 3 virus
  • •In developing countries:
    • –HEV infection is mainly caused by genotype 1 virus
  • •Modes of transmission of indigenous HEV in developed countries:
    • –mainly through the consumption of undercooked meat such as pork
    • –Other modes of transmission:
      • •through blood transfusion, although uncommon
      • •Possibly through organ donation